EVA1C and Alzheimer disease: Third, our results revealed that EVA1C mRNA levels were elevated in AD models, while EVA1C protein levels were reduced, highlighting a disruption of RNA-protein coupling that is consistent with impaired posttranscriptional regulation in neurodegeneration.